Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3, indicating a minor update or fix to the ClinicalTrials.gov page.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page footer shows Revision: v3.6.2, replacing the previous v3.6.0, signaling a system version update rather than a change to the study details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' indicating enrollment closure. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision tag updated to v3.6.0.SummaryDifference0.3%

- Check34 days agoChange DetectedThe footer now shows Revision: v3.5.5, replacing v3.5.4. This appears to be a backend/UI version update with no changes to the study details or user-facing functionality.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, reflecting a newer build/version of the page.SummaryDifference0.0%

- Check70 days agoChange DetectedThe revision tag on the page was updated from v3.5.2 to v3.5.3. This indicates a minor release update to the page, with no substantive content changes evident.SummaryDifference0.0%

Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.